David P. Nicolau, PharmD

Director
Hartford Hospital

Disclosure(s): CARB-X: Grant/Research Support; Innoviva: Advisor/Consultant, Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support

Poster(s):

• (P-1215) In vitro activity of Sulbactam-durlobactam and Standard-of-Care Antibiotics against Acinetobacter baumannii-calcoaceticus complex isolates from wound and urinary tract sources: ACNBio Study 2023-2025
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1260) Beyond Plasma: Defining the Translation Value of Epithelial Lining Fluid Exposure Profiles for the Treatment of Pneumonia
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1362) In vivo Efficacy of an Aztreonam-Avibactam Human Simulated Regimen against Stenotrophomonas maltophilia in the Murine Thigh Infection Model: Decision Support for Susceptibility Breakpoint Determination
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET